Published in Trends Biotechnol on June 09, 2010
Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol (2011) 2.41
High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays. Mol Cell Proteomics (2012) 1.19
High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells. BMC Biotechnol (2013) 1.13
Targeting antibodies to the cytoplasm. MAbs (2011) 1.06
Rise and fall of an anti-MUC1 specific antibody. PLoS One (2011) 0.99
Efficient production of soluble recombinant single chain Fv fragments by a Pseudomonas putida strain KT2440 cell factory. Microb Cell Fact (2011) 0.87
Systematic, spatial imaging of large multimolecular assemblies and the emerging principles of supramolecular order in biological systems. J Mol Recognit (2014) 0.86
Identification of immunogenic proteins and generation of antibodies against Salmonella Typhimurium using phage display. BMC Biotechnol (2012) 0.85
Suppression of p75 neurotrophin receptor surface expression with intrabodies influences Bcl-xL mRNA expression and neurite outgrowth in PC12 cells. PLoS One (2012) 0.84
Generation and analysis of the improved human HAL9/10 antibody phage display libraries. BMC Biotechnol (2015) 0.83
Specific in vivo knockdown of protein function by intrabodies. MAbs (2015) 0.80
The influence of antibody fragment format on phage display based affinity maturation of IgG. MAbs (2014) 0.80
Identification of Novel Immunogenic Proteins of Neisseria gonorrhoeae by Phage Display. PLoS One (2016) 0.79
Phage display-derived human antibodies in clinical development and therapy. MAbs (2016) 0.79
Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen. BMC Biotechnol (2011) 0.78
DeltaPhage--a novel helper phage for high-valence pIX phagemid display. Nucleic Acids Res (2012) 0.77
Single Chain Antibodies as Tools to Study transforming growth factor-β-Regulated SMAD Proteins in Proximity Ligation-Based Pharmacological Screens. Mol Cell Proteomics (2016) 0.76
Selection of recombinant anti-SH3 domain antibodies by high-throughput phage display. Protein Sci (2015) 0.76
pMINERVA: A donor-acceptor system for the in vivo recombineering of scFv into IgG molecules. J Immunol Methods (2016) 0.76
A strategy to identify linker-based modules for the allosteric regulation of antibody-antigen binding affinities of different scFvs. MAbs (2017) 0.75
Expression cloning of camelid nanobodies specific for Xenopus embryonic antigens. PLoS One (2014) 0.75
Mining gut microbiome oligopeptides by functional metaproteome display. Sci Rep (2016) 0.75
Effect of DNA sequence of Fab fragment on yield characteristics and cell growth of E. coli. Sci Rep (2017) 0.75
Intact Transition Epitope Mapping (ITEM). J Am Soc Mass Spectrom (2017) 0.75
ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods (2007) 2.04
Comprehensive catalog of European biobanks. Nat Biotechnol (2011) 1.64
Printing protein arrays from DNA arrays. Nat Methods (2008) 1.39
High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Antimicrob Agents Chemother (2007) 1.27
Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity. BMC Biotechnol (2009) 1.19
Towards proteome scale antibody selections using phage display. N Biotechnol (2009) 1.15
High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells. BMC Biotechnol (2013) 1.13
Double-hexahistidine tag with high-affinity binding for protein immobilization, purification, and detection on ni-nitrilotriacetic acid surfaces. Anal Chem (2006) 1.12
A community standard format for the representation of protein affinity reagents. Mol Cell Proteomics (2009) 1.11
Affinity reagent resources for human proteome detection: initiatives and perspectives. Proteomics (2007) 1.11
Minimum information about a protein affinity reagent (MIAPAR). Nat Biotechnol (2010) 1.10
On the influence of vector design on antibody phage display. J Biotechnol (2006) 1.07
Expression of recombinant antibodies. Front Immunol (2013) 1.06
Protein microarrays: high-throughput tools for proteomics. Expert Rev Proteomics (2009) 1.03
Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV). BMC Biotechnol (2008) 1.03
Phage display derived therapeutic antibodies. Curr Pharm Biotechnol (2008) 1.00
Perspectives for systematic in vitro antibody generation. Gene (2005) 1.00
Rise and fall of an anti-MUC1 specific antibody. PLoS One (2011) 0.99
SRP and Sec pathway leader peptides for antibody phage display and antibody fragment production in E. coli. N Biotechnol (2008) 0.98
Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus. PLoS One (2009) 0.98
Production systems for recombinant antibodies. Front Biosci (2008) 0.96
Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation. J Mol Biol (2007) 0.96
Phage display for the generation of antibodies for proteome research, diagnostics and therapy. Molecules (2011) 0.96
In situ synthesis of protein arrays. Curr Opin Biotechnol (2008) 0.95
European and international collaboration in affinity proteomics. N Biotechnol (2012) 0.92
Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo. PLoS One (2012) 0.92
Affinity maturation by phage display. Methods Mol Biol (2009) 0.91
Affinity proteomics: the role of specific binding reagents in human proteome analysis. Expert Rev Proteomics (2012) 0.90
Evidence for plasticity and structural mimicry at the immunoglobulin light chain-protein L interface. J Biol Chem (2002) 0.90
Obtention and engineering of non-human primate (NHP) antibodies for therapeutics. Mini Rev Med Chem (2009) 0.90
Macrophage migration inhibitory factor plays a role in the regulation of microfold (M) cell-mediated transport in the gut. J Immunol (2008) 0.90
Construction of human antibody gene libraries and selection of antibodies by phage display. Methods Mol Biol (2014) 0.89
Identification of immunogenic polypeptides from a Mycoplasma hyopneumoniae genome library by phage display. Appl Microbiol Biotechnol (2008) 0.88
Eukaryotic ribosome display with in situ DNA recovery. Nat Methods (2007) 0.87
Efficient production of soluble recombinant single chain Fv fragments by a Pseudomonas putida strain KT2440 cell factory. Microb Cell Fact (2011) 0.87
Isolation of scFv fragments specific to OmpD of Salmonella Typhimurium. Vet Microbiol (2010) 0.86
Ribosome display: cell-free protein display technology. Brief Funct Genomic Proteomic (2002) 0.86
Heavy chain-only antibodies are spontaneously produced in light chain-deficient mice. J Exp Med (2007) 0.85
Effects of mutation at the D-JH junction on affinity, specificity, and idiotypy of anti-progesterone antibody DB3. Protein Sci (2006) 0.85
Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin. BMC Biotechnol (2011) 0.85
Production of single chain Fab (scFab) fragments in Bacillus megaterium. Microb Cell Fact (2007) 0.85
Identification of immunogenic proteins and generation of antibodies against Salmonella Typhimurium using phage display. BMC Biotechnol (2012) 0.85
Suppression of p75 neurotrophin receptor surface expression with intrabodies influences Bcl-xL mRNA expression and neurite outgrowth in PC12 cells. PLoS One (2012) 0.84
Improved affinity coupling for antibody microarrays: engineering of double-(His)6-tagged single framework recombinant antibody fragments. Proteomics (2006) 0.84
Scaffolds for protein crystallisation. Acta Crystallogr D Biol Crystallogr (2002) 0.84
Phage display-based identification and potential diagnostic application of novel antigens from Mycoplasma mycoides subsp. mycoides small colony type. Vet Microbiol (2009) 0.84
Construction of human antibody gene libraries and selection of antibodies by phage display. Methods Mol Biol (2010) 0.83
Ribosome display of antibodies: expression, specificity and recovery in a eukaryotic system. J Immunol Methods (2005) 0.82
Production of single chain fragment variable (scFv) antibodies in Escherichia coli using the LEX™ bioreactor. J Biotechnol (2012) 0.82
Development of proteome-wide binding reagents for research and diagnostics. Proteomics Clin Appl (2013) 0.82
Production of recombinant antibody fragments in Bacillus megaterium. Microb Cell Fact (2007) 0.82
Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library. Eur J Immunol (2012) 0.81
Oligomeric forms of single chain immunoglobulin (scIgG). MAbs (2010) 0.81
Oligopeptide m13 phage display in pathogen research. Viruses (2013) 0.81
Production of human single-chain antibodies by ribosome display. Methods Mol Biol (2004) 0.81
Influence of the hydromechanical stress and temperature on growth and antibody fragment production with Bacillus megaterium. Appl Microbiol Biotechnol (2011) 0.80
A methodological approach to investigate steady state fucoxanthin chlorophyll a/c binding protein mRNA levels in Wadden Sea sediments. Int Microbiol (2003) 0.80
The influence of antibody fragment format on phage display based affinity maturation of IgG. MAbs (2014) 0.80
Workshop on laboratory protocol standards for the Molecular Methods Database. N Biotechnol (2012) 0.80
DiscernArray technology: a cell-free method for the generation of protein arrays from PCR DNA. J Immunol Methods (2003) 0.78
Detection of protein-protein interactions by ribosome display and protein in situ immobilisation. N Biotechnol (2009) 0.78
Encapsulation of proteins in hydrogel carrier systems for controlled drug delivery: influence of network structure and drug size on release rate. J Biotechnol (2012) 0.78
Chemical inhibitors when timing is critical: a pharmacological concept for the maturation of T cell contacts. Chembiochem (2005) 0.78
Antibody production in Bacillus megaterium: strategies and physiological implications of scaling from microtiter plates to industrial bioreactors. Biotechnol J (2011) 0.78
Phospho-specific antibodies by design. Nat Biotechnol (2013) 0.78
Eukaryotic ribosome display with in situ DNA recovery. Methods Mol Biol (2012) 0.78
Recombinant antibody fragments allow repeated measurements of C-reactive protein with a quartz crystal microbalance immunosensor. MAbs (2012) 0.77
Protein microarrays printed from DNA microarrays. Methods Mol Biol (2011) 0.77
Optimised 'on demand' protein arraying from DNA by cell free expression with the 'DNA to Protein Array' (DAPA) technology. J Proteomics (2013) 0.77
Production of protein arrays by cell-free systems. Methods Mol Biol (2008) 0.77
Human antibodies targeting CD30(+) lymphomas. Hum Antibodies (2012) 0.77
Enhanced cell-free protein expression by fusion with immunoglobulin Ckappa domain. Protein Sci (2006) 0.76
Cell free expression put on the spot: advances in repeatable protein arraying from DNA (DAPA). N Biotechnol (2010) 0.76
In situ biosynthesis of peptide arrays. Methods Mol Biol (2010) 0.75
Antibody production by the gram-positive bacterium Bacillus megaterium. Methods Mol Biol (2009) 0.75
Linear Discriminant Analysis Identifies Mitochondrially Localized Proteins in Neurospora crassa. J Proteome Res (2015) 0.75
Selection of antigenic markers on a GFP-Ckappa fusion scaffold with high sensitivity by eukaryotic ribosome display. Biochem Biophys Res Commun (2007) 0.75
Producing protein microarrays from DNA microarrays. Methods Mol Biol (2011) 0.75
A peptide-functionalized polymer as a minimal scaffold protein to enhance cluster formation in early T cell signal transduction. Chembiochem (2015) 0.75
On the trail to therapeutic antibodies. N Biotechnol (2011) 0.75
"4D Biology for health and disease" workshop report. N Biotechnol (2010) 0.75
New Biotechnology and the European Federation of Biotechnology. N Biotechnol (2008) 0.75
Selection of recombinant antibodies by eukaryotic ribosome display. Methods Mol Biol (2008) 0.75
Fruits of the ESF Research Networking Programme in Functional Genomics. N Biotechnol (2013) 0.75